Every quarter has a headline number, and Q1 2026's is a good one. European venture funding hit $17.6 billion, up nearly 30% year-over-year — the second consecutive quarter of growth. PitchBook puts the figure at €21.9 billion, the strongest quarter in nearly four years. Depending on which dataset you trust, European VC is either firmly back or quietly storming.

But the headline number is hiding what's actually going on underneath. I've spent the last few weeks tracking the data, the deals, and the conversations happening across European VC, and there are five trends that I think every investor — whether you're running a fund, deploying family office capital, or writing angel cheques — needs to be paying attention to right now.

See below to continue…

SoPhy helps founders, investors and operators keep track of every person they meet. Add context, set follow-up reminders, and search your entire network instantly - so the right people never slip through the cracks again.

Waitlist is open. Won't be forever.

Refer. Earn RF$. Win prizes.
Make one referral and start earning - our 3-layer system pays you RF$ when your referrals refer too. Swap for raffle tickets.

£350,000 in prizes.

More details here.

Continue…

Q1's growth wasn't broad 0 it was wildly concentrated. Average deal sizes in Europe have nearly tripled year-over-year, from €35.9 million to €90.5 million, driven by a small number of AI and robotics mega-rounds. KPMG's European Venture Pulse puts it bluntly: activity remained "highly selective and concentrated among large, established companies", with investors still cautious about earlier-stage and higher-risk opportunities.

In plain English: late-stage AI is being bid up to the moon. Everything else is still hard.

For LPs and allocators, this creates a sharp question. If you're invested in funds writing seed and Series A cheques outside AI, your portfolio companies are operating in a market that hasn't really recovered. If you're invested in growth-stage AI funds, you're paying prices that would have been considered insane two years ago and might still be cheap two years from now.

There's no obviously correct answer here. But pretending it's one market when it's clearly two is the most expensive mistake you can make this year.

This is genuinely historic. AI claimed more than half of European venture funding in Q1 for the first time on record. Not most quarters. Not most years. Ever.

For investors, this isn't just a sector observation - it's a portfolio construction question. If your fund or your direct portfolio has less than 50% AI exposure, you are now under-indexed to where capital is flowing in Europe. That might be a deliberate contrarian bet (and there's a real argument for one - see point 5). But it should be deliberate. Most allocators I've spoken to recently haven't actually run the numbers on their AI exposure, and the gap between where they think they are and where they actually are can be uncomfortable.

The flipside: if everyone is allocating to AI, the returns on incremental AI capital have to come down at some point. The question is whether "at some point" is this year, in three years, or when the IPO window finally cracks open for the labs themselves.

If you missed this one, pay attention. On 4 May, SAP announced it was acquiring German AI startup Prior Labs, with a commitment to invest over €1 billion ($1.16 billion) into the business over four years. The actual purchase price wasn't disclosed, but TechCrunch's sources describe it as an "almost all cash" deal with well over half a billion dollars in cash up front for the three founders.

Prior Labs was 18 months old. It had raised exactly one round - a €9 million seed in February 2025, led by Balderton with Atlantic Labs and XTX Ventures participating.

Let that sink in. An 18-month-old European AI startup, one funding round, exits for ten figures.

For European seed-stage AI investors, this is the proof point they've been waiting for. The thesis that you can find category-defining AI labs early in Europe - not just back the US giants at 100x markup - just got real. Expect every European seed fund to use this deal in their next LP deck. Expect family offices that have been on the sidelines of European AI to take a second look. And expect a wave of new seed funds raising specifically against this thesis in the second half of 2026.

The flip side: Prior Labs was built around genuinely differentiated science (tabular foundation models published in Nature, with state-of-the-art benchmarks). This wasn't a wrapper company or a thin GPT layer. The lesson isn't "any European AI seed deal will do" - it's that deep technical moats in unsexy enterprise categories can produce outsized exits faster than the conventional venture timeline suggests.

This one didn't get nearly enough attention, and it should have. In the past few weeks, both Anthropic and OpenAI announced major joint ventures with the world's largest private equity firms. Anthropic launched a JV with Blackstone, Hellman & Friedman, and Goldman Sachs to deploy AI inside enterprise portfolio companies. OpenAI announced a similar initiative with TPG, Bain Capital, and Brookfield.

The mechanics are genuinely novel. PE firms have spent twenty years optimising their portfolios to within an inch of their lives, and EBITDA expansion has become increasingly hard to manufacture. AI offers a fresh lever - embed it deeply into a portfolio company's operations, juice the margins by 10-15%, and suddenly your returns story works again. For Anthropic and OpenAI, this creates locked-in enterprise distribution and predictable revenue at a scale that even hyperscaler partnerships can't match.

Roughly 7% of US GDP sits in PE-backed companies - somewhere between $8 and $9 trillion in market cap. If even a fraction of that gets re-rated through AI deployment, the implications for both PE returns and frontier lab revenue are enormous.

For family offices and allocators thinking about where to deploy capital this year, this is potentially the most important capital structure innovation of the cycle. It's not pure VC. It's not pure PE. It's a hybrid that creates a new way to ride AI's enterprise penetration without paying frontier lab valuations directly. Worth understanding which of your PE managers are leaning in - and which are getting left behind.

Easy to miss in the noise, but venture debt deployed €5.9 billion in Q1 alone - on track to exceed 2025's full year by more than 18%. Average deal sizes are jumping, fuelled by AI infrastructure plays like Nscale's $1.4 billion debt raise ahead of a $2 billion Series C.

Why does this matter for an investor audience? Two reasons.

First, it's a signal that AI infrastructure has matured into something underwriteable as debt - meaning the cash flows are predictable enough that lenders will take the risk. That's a real shift, and it changes how growth-stage AI companies will be financed going forward.

Second, for family offices and allocators looking for AI exposure without late-stage equity risk, venture debt funds are now a legitimate part of the conversation. The yields are attractive, the duration is shorter than equity, and the downside is materially protected. It's not going to deliver venture-style outsized returns, but for the part of your portfolio that wants AI participation with some capital preservation, this is a category worth a real look this year.

What I take away from all this: European VC is finally producing the headline numbers we've all been waiting for, but the underlying story is more complicated than the headlines suggest. The opportunity has narrowed dramatically - to AI, to a handful of mega-rounds, to a small number of category-defining seed deals like Prior Labs, and to new structures like the PE-frontier lab JVs.

For investors paying attention, this is one of the most interesting moments in European venture in a decade. For investors operating on autopilot, it's one of the easiest to get wrong.

The next 12 months won't be about whether you allocate to AI. It'll be about how - at which stage, through which structure, with which managers, and against which thesis. Most of the gap between great and average returns from here will come from getting those four answers right.

✅ Know an investor, allocator, or family office principal trying to make sense of where European VC is actually heading? Forward this their way. The clearer the picture they have of how the market has bifurcated, the better the allocation decisions they'll make this year.

✅ We also share this list in our founder-focused newsletter. Want to be featured next time? Send me a note.

We've built the ultimate aggregator of all UK startup events.
All the UK's best startup events in one place.

Access here and please share with others!

Tech brands are flooding F1 (34 sponsors in 2026, up 70% from last year). Motorsport is where elite connections happen.

Now enter the room: A private BTCC weekend at Silverstone, 26-27 Sept 2026. Thirty hand-picked family offices, fund GPs, and senior execs only.

What's included:

Not for sale. Invite-only. The right thirty get in.

Register interest here - selected for fit & value to the room.

If you found this roundup useful, share it with another investor who should be in the loop. The bigger our community, the more opportunities we can create together.